3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Papillomavirus Infections
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Myeloma
3
Lymphoma, Follicular
3
Triple Negative Breast Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thymic aplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pneumonia
1
Osteosarcoma
1
Obesity
1
Neurofibromatosis 1
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
trametinib
1
thymoglobulin
1
fludarabine
1
ensartinib
1
dabrafenib
1
Whole-Body Irradiation
1
Tacrolimus
1
Rituximab
1
Pharmacogenomic Variants
1
Mycophenolic Acid
1
Melphalan
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Histiocytosis, Langerhans-Cell
×
Blood Specimen Collection
×
Clear all
No trials found.